343 related articles for article (PubMed ID: 12924709)
1. Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells.
Bouvier C; Bartoli C; Aguirre-Cruz L; Virard I; Colin C; Fernandez C; Gouvernet J; Figarella-Branger D
J Neurosurg; 2003 Aug; 99(2):344-50. PubMed ID: 12924709
[TBL] [Abstract][Full Text] [Related]
2. Expression of oligodendrocyte lineage genes in oligodendroglial and astrocytic gliomas.
Riemenschneider MJ; Koy TH; Reifenberger G
Acta Neuropathol; 2004 Mar; 107(3):277-82. PubMed ID: 14730454
[TBL] [Abstract][Full Text] [Related]
3. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Ligon KL; Alberta JA; Kho AT; Weiss J; Kwaan MR; Nutt CL; Louis DN; Stiles CD; Rowitch DH
J Neuropathol Exp Neurol; 2004 May; 63(5):499-509. PubMed ID: 15198128
[TBL] [Abstract][Full Text] [Related]
4. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.
Ohnishi A; Sawa H; Tsuda M; Sawamura Y; Itoh T; Iwasaki Y; Nagashima K
J Neuropathol Exp Neurol; 2003 Oct; 62(10):1052-9. PubMed ID: 14575240
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.
Lu QR; Park JK; Noll E; Chan JA; Alberta J; Yuk D; Alzamora MG; Louis DN; Stiles CD; Rowitch DH; Black PM
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10851-6. PubMed ID: 11526205
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.
Aguirre-Cruz L; Mokhtari K; Hoang-Xuan K; Marie Y; Criniere E; Taillibert S; Lopes M; Delattre JY; Sanson M
J Neurooncol; 2004 May; 67(3):265-71. PubMed ID: 15164981
[TBL] [Abstract][Full Text] [Related]
7. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
8. Predominant expression of OLIG2 over ID2 in oligodendroglial tumors.
Mikami S; Hirose Y; Yoshida K; Kawase T; Ohnishi A; Nagashima K; Mukai M; Okada Y; Ikeda E
Virchows Arch; 2007 May; 450(5):575-84. PubMed ID: 17431671
[TBL] [Abstract][Full Text] [Related]
9. OLIG2 as a specific marker of oligodendroglial tumour cells.
Marie Y; Sanson M; Mokhtari K; Leuraud P; Kujas M; Delattre JY; Poirier J; Zalc B; Hoang-Xuan K
Lancet; 2001 Jul; 358(9278):298-300. PubMed ID: 11498220
[TBL] [Abstract][Full Text] [Related]
10. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
11. OLIG-1 and 2 gene expression and oligodendroglial tumours.
Hoang-Xuan K; Aguirre-Cruz L; Mokhtari K; Marie Y; Sanson M
Neuropathol Appl Neurobiol; 2002 Apr; 28(2):89-94. PubMed ID: 11972795
[TBL] [Abstract][Full Text] [Related]
12. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
13. Gain-of-function of Olig transcription factors enhances oligodendrogenesis and myelination.
Maire CL; Wegener A; Kerninon C; Nait Oumesmar B
Stem Cells; 2010 Sep; 28(9):1611-22. PubMed ID: 20672298
[TBL] [Abstract][Full Text] [Related]
14. Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3.
Takebayashi H; Yoshida S; Sugimori M; Kosako H; Kominami R; Nakafuku M; Nabeshima Y
Mech Dev; 2000 Dec; 99(1-2):143-8. PubMed ID: 11091082
[TBL] [Abstract][Full Text] [Related]
15. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation.
Samanta J; Kessler JA
Development; 2004 Sep; 131(17):4131-42. PubMed ID: 15280210
[TBL] [Abstract][Full Text] [Related]
16. Olig gene function in CNS development and disease.
Ligon KL; Fancy SP; Franklin RJ; Rowitch DH
Glia; 2006 Jul; 54(1):1-10. PubMed ID: 16652341
[TBL] [Abstract][Full Text] [Related]
17. SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: An immunohistochemical study of 98 glial tumors.
Švajdler M; Rychlý B; Mezencev R; Fröhlichová L; Bednárová A; Pataky F; Daum O
Histol Histopathol; 2016 Jan; 31(1):95-102. PubMed ID: 26287936
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of immune defense genes in pilocytic astrocytomas.
Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
[TBL] [Abstract][Full Text] [Related]
19. Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma.
Gupta M; Djalilvand A; Brat DJ
Am J Clin Pathol; 2005 Nov; 124(5):755-68. PubMed ID: 16203285
[TBL] [Abstract][Full Text] [Related]
20. Human Dental Pulp Stem Cells Differentiate into Oligodendrocyte Progenitors Using the Expression of Olig2 Transcription Factor.
Askari N; Yaghoobi MM; Shamsara M; Esmaeili-Mahani S
Cells Tissues Organs; 2014; 200(2):93-103. PubMed ID: 25966902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
